March 20, 2025 - 20:32

Leaders at Hennepin Healthcare, which operates the largest emergency room in the state, are expressing deep concerns regarding potential federal cuts to Medicaid. They warn that such cuts could lead to a surge in patients arriving at emergency departments with serious and preventable health conditions. The implications of these cuts could strain already overburdened hospitals and clinics, making it increasingly difficult to provide adequate care to those in need.
As Congressional Republicans push for tax cuts that primarily benefit wealthier individuals, healthcare leaders argue that this could come at a significant cost to public health. The fear is that without sufficient funding for Medicaid, vulnerable populations may face diminished access to necessary medical services, ultimately resulting in more severe health crises that require emergency intervention.
This situation highlights the ongoing tension between fiscal policy and healthcare accessibility, raising critical questions about the future of state healthcare systems amidst potential budgetary constraints.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....